<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04536714</url>
  </required_header>
  <id_info>
    <org_study_id>Prot.1 26/8/2020</org_study_id>
    <nct_id>NCT04536714</nct_id>
  </id_info>
  <brief_title>Efficacy of Pythagorean Self-Awareness Intervention for Major Depressive Disorder</brief_title>
  <official_title>Stress and Depression: Interventional, Non-pharmaceutical Stress Management Program With the Cognitive Restructuring Method &quot;Pythagorean Self-Awareness&quot; for Patients Diagnosed With Major Depressive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Evgenia E. Psarraki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National and Kapodistrian University of Athens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study explored the effects of the implementation of the Pythagorean Self Awarenes&#xD;
      Intervention (PSAI) on patients diagnosed with major depressive disorder. The primary aim was&#xD;
      to evaluate the effectiveness of PSAI compared to the usual care provided for adults with&#xD;
      major depressive disorder with respect to the reduction of depressive symptoms. Secondary&#xD;
      aims of this study included reduction of stress and anxiety, enhancement of healthy lifestyle&#xD;
      and improvement of affect, sleep quality and cognitive functions of patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design This randomized controlled trial was conducted at the Mental Health Center of&#xD;
      Peristeri, department of the Psychiatric Hospital of Attica, Greece, from December 2018 to&#xD;
      January 2020. The study protocol was approved by the School of Medicine, National and&#xD;
      Kapodistrian University of Athens (Protocol n. 1718038002/30/07/2018) and the center's&#xD;
      directorate and was consistent with the Declaration of Helsinki. All participants were&#xD;
      enlisted in the study only after being fully informed by the researcher about the aims and&#xD;
      procedures of the research and submitting written consent.&#xD;
&#xD;
      Procedures Patients eligible for the above mentioned criteria were randomized in two groups:&#xD;
      the intervention group, receiving PSAI, and the control group, receiving the usual care&#xD;
      provided by the center for patients with MDD, namely medical treatment and counselling.&#xD;
      Randomization was conducted based on random numbers generated by an online random number&#xD;
      generator (https://www.sealedenvelope.com/simple-randomiser/v1/lists). This study was&#xD;
      non-blinded, as patients and researchers were aware of the group assignment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 3, 2018</start_date>
  <completion_date type="Actual">January 21, 2020</completion_date>
  <primary_completion_date type="Actual">January 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Beck Depression Inventory-II</measure>
    <time_frame>2 months</time_frame>
    <description>self-report questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Healthy Lifestyle and Personal Control Questionnaire</measure>
    <time_frame>2 months</time_frame>
    <description>self-report questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression-Anxiety-Stress Scale-21</measure>
    <time_frame>2 months</time_frame>
    <description>self-report questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive and Negative Affect Schedule</measure>
    <time_frame>2 months</time_frame>
    <description>self-report questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburg Sleep Quality Index</measure>
    <time_frame>2 months</time_frame>
    <description>self-report questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brief International Assessment of Cognition for Multiple Sclerosis</measure>
    <time_frame>2 months</time_frame>
    <description>battery of three cognitive tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hair cortisol concentration</measure>
    <time_frame>2 months</time_frame>
    <description>Hair specimens from the posterior vertex of the scalp, three proximal to scalp cms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Salivary cortisol concentration</measure>
    <time_frame>2 months</time_frame>
    <description>saliva specimens,three measurements in 24 hours: two in the morning (on awakening and 40 minutes later) and one at night (at 8:00). CAR and diurnal slope of cortisol were also calculated</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>34 participants. Received Pythagorean Self-Awareness program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>35 participants. Received usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Pythagorean Self-Awareness Intervention program</intervention_name>
    <description>Stress management program of Pythagorean Self-Awareness Intervention (PSAI), which included eight sessions and lasted for eight weeks. On the first week, a personal session took place for measurements and training in the relaxation technique of diaphragmatic breathing. In the second week, patients attended a group session, in which they were adviced to follow specific directions for a healthy lifestyle, such as organized physical activity, adherence to the Mediterranean diet, creating a daily routine. In the third week, participants were introduced to the cognitive restructuring technique of (PSAI).In the following four group sessions, patients were trained on PSAI and the second relaxation technique, progressive muscular relaxation. In the last week, the final measurements were made. All sessions lasted for 120 minutes, except for the final one, which lasted for 60 minutes.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  major depressive disorder diagnosis conducted by a psychiatrist of the center&#xD;
             according to the DSM-V criteria&#xD;
&#xD;
          -  residency in Attica&#xD;
&#xD;
          -  ability to speak and write fluently in the Greek language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  antecedent psychotic or manic episode&#xD;
&#xD;
          -  current feeding or eating disorder, obsessive-compulsive disorder, self-harming&#xD;
             behaviors or recent suicide attempt and current drug abuse or addiction&#xD;
&#xD;
          -  current treatment with Cognitive-Behavioral Therapy&#xD;
&#xD;
          -  denial to participate in the research&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evgenia E Psarraki, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>MSc &quot;The Science of Stress and Health Promotion&quot;, School of Medicine, NKU Athens</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christina Darviri, Dr</last_name>
    <role>Study Director</role>
    <affiliation>MSc &quot;The Science of Stress and Health Promotion&quot;, School of Medicine, NKU Athens</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mental Health Center of Peristeri, department of the Psychiatric Hospital of Attica, Ploutonos 19</name>
      <address>
        <city>Peristeri</city>
        <state>Attica</state>
        <zip>12135</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol. 2012 Jan;233(1):102-11. doi: 10.1016/j.expneurol.2011.10.032. Epub 2011 Nov 7. Review.</citation>
    <PMID>22101006</PMID>
  </reference>
  <reference>
    <citation>Hammen C. Stress and depression. Annu Rev Clin Psychol. 2005;1:293-319. Review.</citation>
    <PMID>17716090</PMID>
  </reference>
  <reference>
    <citation>Dean J, Keshavan M. The neurobiology of depression: An integrated view. Asian J Psychiatr. 2017 Jun;27:101-111. doi: 10.1016/j.ajp.2017.01.025. Epub 2017 Jan 29. Review.</citation>
    <PMID>28558878</PMID>
  </reference>
  <reference>
    <citation>Winnebeck E, Fissler M, Gärtner M, Chadwick P, Barnhofer T. Brief training in mindfulness meditation reduces symptoms in patients with a chronic or recurrent lifetime history of depression: A randomized controlled study. Behav Res Ther. 2017 Dec;99:124-130. doi: 10.1016/j.brat.2017.10.005. Epub 2017 Oct 12.</citation>
    <PMID>29078199</PMID>
  </reference>
  <reference>
    <citation>Wetherell JL, Hershey T, Hickman S, Tate SR, Dixon D, Bower ES, Lenze EJ. Mindfulness-Based Stress Reduction for Older Adults With Stress Disorders and Neurocognitive Difficulties: A Randomized Controlled Trial. J Clin Psychiatry. 2017 Jul;78(7):e734-e743. doi: 10.4088/JCP.16m10947.</citation>
    <PMID>28686822</PMID>
  </reference>
  <reference>
    <citation>Meyer B, Berger T, Caspar F, Beevers CG, Andersson G, Weiss M. Effectiveness of a novel integrative online treatment for depression (Deprexis): randomized controlled trial. J Med Internet Res. 2009 May 11;11(2):e15. doi: 10.2196/jmir.1151.</citation>
    <PMID>19632969</PMID>
  </reference>
  <reference>
    <citation>Rentala S, Fong TC, Nattala P, Chan CL, Konduru R. Effectiveness of body-mind-spirit intervention on well-being, functional impairment and quality of life among depressive patients - a randomized controlled trial. J Adv Nurs. 2015 Sep;71(9):2153-63. doi: 10.1111/jan.12677. Epub 2015 May 12.</citation>
    <PMID>25967378</PMID>
  </reference>
  <reference>
    <citation>Darviri, C., Zavitsanou, C., Delikou, A., Giotaki, A., Artemiadis, A., Terentiou, A., &amp; Chrousos, G. P. (2016). A novel non-pharmaceutical treatment for patients with mild cognitive impairment. Psychology, 7(5), 678-686.</citation>
  </reference>
  <reference>
    <citation>Tsoli S, Vasdekis S, Tigani X, Artemiadis A, Chrousos G, Darviri C. A novel cognitive behavioral treatment for patients with chronic insomnia: A pilot experimental study. Complement Ther Med. 2018 Apr;37:61-63. doi: 10.1016/j.ctim.2018.01.015. Epub 2018 Feb 1.</citation>
    <PMID>29609939</PMID>
  </reference>
  <reference>
    <citation>Charalampopoulou M, Bacopoulou F, Syrigos KN, Filopoulos E, Chrousos GP, Darviri C. The effects of Pythagorean Self-Awareness Intervention on breast cancer patients undergoing adjuvant therapy: A pilot randomized controlled trial. Breast. 2020 Feb;49:210-218. doi: 10.1016/j.breast.2019.12.012. Epub 2019 Dec 20.</citation>
    <PMID>31901782</PMID>
  </reference>
  <reference>
    <citation>Darviri C, Alexopoulos EC, Artemiadis AK, Tigani X, Kraniotou C, Darvyri P, Chrousos GP. The Healthy Lifestyle and Personal Control Questionnaire (HLPCQ): a novel tool for assessing self-empowerment through a constellation of daily activities. BMC Public Health. 2014 Sep 24;14:995. doi: 10.1186/1471-2458-14-995.</citation>
    <PMID>25253039</PMID>
  </reference>
  <reference>
    <citation>Beck, A. T., Steer, R. A., &amp; Brown, G. K. (1996). Beck depression inventory-II. San Antonio, 78(2), 490-498.</citation>
  </reference>
  <reference>
    <citation>Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43.</citation>
    <PMID>7726811</PMID>
  </reference>
  <reference>
    <citation>Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70.</citation>
    <PMID>3397865</PMID>
  </reference>
  <reference>
    <citation>Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213.</citation>
    <PMID>2748771</PMID>
  </reference>
  <reference>
    <citation>Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hämäläinen P, Hartung HP, Krupp L, Penner IK, Reder AT, Benedict RH. Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS). Mult Scler. 2012 Jun;18(6):891-8. doi: 10.1177/1352458511431076. Epub 2011 Dec 21. Review.</citation>
    <PMID>22190573</PMID>
  </reference>
  <reference>
    <citation>Wester VL, van Rossum EF. Clinical applications of cortisol measurements in hair. Eur J Endocrinol. 2015 Oct;173(4):M1-10. doi: 10.1530/EJE-15-0313. Epub 2015 Apr 29. Review.</citation>
    <PMID>25924811</PMID>
  </reference>
  <reference>
    <citation>Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994;19(4):313-33. Review.</citation>
    <PMID>8047637</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 26, 2020</study_first_submitted>
  <study_first_submitted_qc>August 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 3, 2020</study_first_posted>
  <last_update_submitted>August 28, 2020</last_update_submitted>
  <last_update_submitted_qc>August 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>National and Kapodistrian University of Athens</investigator_affiliation>
    <investigator_full_name>Evgenia E. Psarraki</investigator_full_name>
    <investigator_title>MSc</investigator_title>
  </responsible_party>
  <keyword>major depression</keyword>
  <keyword>stress management program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

